Cardiocomm Solutions Inc. announced that it expects to receive CAD 0.15 million in funding
January 29, 2017
Share
Cardiocomm Solutions Inc. (TSXV:EKG) announced a non-brokered private placement of up to 3,000,000 units at a price of CAD 0.05 per unit for gross proceeds of up to CAD 150,000 on January 29, 2017. Each unit consists of one common share and one common share purchase warrant. Each warrant can be exercised to acquire one common share at a price of CAD 0.075 per share for a period of two years from the date of closing. The transaction is subject to approval from TSX Venture Exchange. The securities are being subject to four months hold period.
CardioComm Solutions, Inc. is a Canada-based company, which develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company's specialization is in the software engineering of computer based (ECG) management and reporting software. The software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings. The Companyâs device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for the recording, transmission, viewing, analyzing, reporting and storage of electrocardiograms, for arrhythmia screening, diagnosis, and management of cardiac patients. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians.
CARDIOCOMM SOLUTIONS, INC. 
